Cancer BiologybioRxivPreprint
Next-generation all-in-one CRISPR/Cas9 multiply-edited CD30CAR-T cells:Potency despite risk of translocations
Jan-Malte Kleid, Michael Damrat, Milita Darguzyte…·Renata Stripecke
This study develops next-generation CD30CAR-T cells using CRISPR/Cas9 for multiplex editing, showing high potency but risks of translocations with combined knockouts.